Exodus Point Capital Management, LP Athira Pharma, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$9.17 - $16.39 $132,213 - $236,311	-14,418 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.15 - $11.09 $34,019 - $41,232	3,718 Added 34.75%	14,418 $135,000
Q2 2021 Aug 16, 2021	BUY	$10.24 - $20.87 $109,568 - $223,309	10,700 New	10,700 $110,000
Q1 2021 May 17, 2021	SELL	$16.9 - $29.77 $130,079 - $229,139	-7,697 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.48 - $34.3 $976,390 - $2.03 Million	-59,247 Reduced 88.5%	7,697 $264,000
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $1.07 Million - $1.24 Million	66,944 New	66,944 $1.24 Million

22.8M

73.4K

97.8K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $16.3M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.